Topics:
Medical Oncology • Neuroendocrine Tumors • NCI-CCC Tumor Board Question • NCI-CCC Neuroendocrine Tumor Board • Case Western
For patients with well differentiated NET whose carcinoid symptoms are controlled on SSAs but have persistently elevated 5HIAA, would you consider adding telotristat for prevention of carcinoid heart disease?
How aggressive should we be in bringing elevated plasma/urine 5HIAA to normal levels in patients whose symptoms are controlled? Before we have the results of the ongoing study, should we routinely consider adding telotristat?